Effect of IBD medications on COVID-19 outcomes: results from an international registry

OBJECTIVE: We sought to evaluate COVID-19 clinical course in patients with IBD treated with different medication classes and combinations. DESIGN: Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gut
Autori principali: Ungaro, Ryan C, Brenner, Erica J, Gearry, Richard B, Kaplan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-Francois, Reinisch, Walter, Steinwurz, Flávio, Underwood, Fox E, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2021
Soggetti:
Covid-19
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8136807/
https://ncbi.nlm.nih.gov/pubmed/33082265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2020-322539
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi